These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
24. Benign-appearing mesothelioma cells in a serous effusion. Guffanti MC; Faleri ML Acta Cytol; 1985; 29(1):90-2. PubMed ID: 3855595 [No Abstract] [Full Text] [Related]
25. Ultrastructure of human mesotheliomas. Davis JM J Natl Cancer Inst; 1974 Jun; 52(6):1715-25. PubMed ID: 4365387 [No Abstract] [Full Text] [Related]
27. [Malignant mesothelioma of the peritoneum]. Iudakova TM Arkh Patol; 1982; 44(5):62-4. PubMed ID: 7115133 [TBL] [Abstract][Full Text] [Related]
28. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain. Yang GC Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641 [TBL] [Abstract][Full Text] [Related]
29. [Cytologic diagnosis of metastases of stomach cancer during laparoscopy]. Petrova AS; Agadzhanova AKh; Gubin AN Lab Delo; 1989; (6):9-11. PubMed ID: 2474724 [TBL] [Abstract][Full Text] [Related]
30. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY; Li GD; Liu HB; Jiang LL Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [TBL] [Abstract][Full Text] [Related]
31. The pathology of benign and malignant pleural disease. Hammar SP Chest Surg Clin N Am; 1994 Aug; 4(3):405-30. PubMed ID: 7953476 [TBL] [Abstract][Full Text] [Related]
32. Malignant mesothelial tumors - histologic type and asbestos exposure. Magner D; McDonald AD N Engl J Med; 1972 Sep; 287(11):570-1. PubMed ID: 5050439 [No Abstract] [Full Text] [Related]
33. [A case report of diffuse malignant pleural mesothelioma combined with follicular thyroid carcinoma, and a biochemical study on its glycosaminoglycans]. Nakano T; Maebo A; Moriwaki Y; Iwahashi N; Tamura S; Nabeshima K; Higashino K; Nakata Y; Horai T Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Nov; 21(11):1117-21. PubMed ID: 6677786 [No Abstract] [Full Text] [Related]
35. Malignant mesothelioma presenting in the pleura and peritoneum. Wouters EF; Havenith MG; Vermeulen A; Greve LH Neth J Med; 1984; 27(6):213-7. PubMed ID: 6462309 [No Abstract] [Full Text] [Related]
36. Podoplanin as a marker for mesothelioma. Kimura N; Kimura I Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854 [TBL] [Abstract][Full Text] [Related]
37. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status. Kobayashi M; Takeuchi T; Ohtsuki Y Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846 [TBL] [Abstract][Full Text] [Related]
38. Recognition of malignant cells in pleural and peritoneal effusions. Bakalos D; Constantakis N; Tsicricas T Acta Cytol; 1974; 18(2):118-21. PubMed ID: 4133106 [No Abstract] [Full Text] [Related]
39. [On the use of the PAS reaction for the identification of mesothelial cells (compilation and critical examination of the results)]. Mavrommatis F Acta Histochem; 1965 Aug; 21(5):201-12. PubMed ID: 4158593 [No Abstract] [Full Text] [Related]
40. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Kwee WS; Veldhuizen RW; Alons CA; Morawetz F; Boon ME Acta Cytol; 1982; 26(4):401-6. PubMed ID: 6957089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]